Hem › Akut myeloid leukemi › Georgia › Augusta
Kliniska studier för Akut myeloid leukemi i Augusta, GA
10 studier för Akut myeloid leukemi söker deltagare vid platser i och runt Augusta (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekryterarFas 2
- Augusta University Medical Center, Augusta
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- Augusta University Medical Center, Augusta
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- Augusta University Medical Center, Augusta
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- Augusta University Medical Center, Augusta
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekryterarFas 3
- Augusta University Medical Center, Augusta
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekryterarFas 1
- Georgia Cancer Center at Augusta University, Augusta
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
RekryterarFas 2/3
- Augusta University - Georgia Cancer Center, Augusta
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekryterarObservationsstudie
- Georgia Cancer Center at Augusta University Health, Augusta
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekryterarFas 1
- Georgia Cancer Center at Augusta University, Augusta
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
RekryterarFas 2
- Georgia Cancer Center at Augusta University, Augusta
Akut myeloid leukemi-studier i andra städer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Baldwin Park, CA40 studier
- Seattle, WA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA30 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
Andra studier i Augusta
- Äggstockscancer8 studier
- Endometriecancer7 studier
- Cancer (alla typer)7 studier
- Sickelcellssjukdom5 studier
- Bröstcancer5 studier
- Myasthenia gravis4 studier
- Blodcancer4 studier
- Burkitts lymfom4 studier
- Diffust storcelligt B-cellslymfom4 studier
- Kronisk myeloisk leukemi4 studier
- Non-Hodgkins lymfom4 studier
- Livmoderhalscancer4 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.